share_log

MusclePharm (OTCMKTS:MSLP) Stock Passes Below Two Hundred Day Moving Average of $0.20

MusclePharm (OTCMKTS:MSLP) Stock Passes Below Two Hundred Day Moving Average of $0.20

MusclePharm(场外交易代码:MSLP)股价跌破200日移动均线0.20美元
Defense World ·  2022/11/01 03:11

MusclePharm Co. (OTCMKTS:MSLP – Get Rating)'s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.20 and traded as low as $0.10. MusclePharm shares last traded at $0.10, with a volume of 23,260 shares changing hands.

在周一的交易中,MusclePharmCo.的股价跌破200日移动均线,200日移动均线切入位为0.20美元,最低交易价格为0.10美元。MusclePharm的股票最新报0.10美元,总成交量为23,260股。

MusclePharm Stock Performance

MusclePharm股票表现

The stock has a market capitalization of $3.34 million, a price-to-earnings ratio of -0.17 and a beta of 0.38. The company's 50 day moving average is $0.18 and its 200 day moving average is $0.20.

该股市值334万美元,市盈率为-0.17,贝塔系数为0.38。该公司的50日移动均线切入位在0.18美元,200日移动均线切入位在0.20美元。

About MusclePharm

关于MusclePharm

(Get Rating)

(获取评级)

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.

公司在美国和国际上开发、制造、营销和分销运动营养品和营养补充剂。该公司提供一系列高性能粉末、胶囊、片剂、凝胶和随时可用的零食。该公司的MusclePharm品牌产品组合包括战斗蛋白粉和战斗挤压蛋白棒;以及支链氨基酸、肌酸、谷氨酰胺、肉碱、共轭亚油酸、鱼油、多种维生素和其他产品等基本补充剂。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on MusclePharm (MSLP)
  • Here's Why Harley-Davidson is Roaring Higher
  • As Mega Caps Get Crushed, This Mid Cap Tech Stock Is Crushing It
  • Why Investors Are Suddenly Excited About Vaxcyte
  • Saia Stock Is Ready To Switch Gears And Move Higher
  • Is The Meta Platforms Stock Meltdown a Rare Buying Opportunity?
  • 免费获取StockNews.com关于MusclePharm的研究报告(MSLP)
  • 这就是为什么哈雷-戴维森公司在咆哮
  • 随着Mega Caps被压垮,这只中型股科技股正在压垮它
  • 为什么投资者突然对Vaxcell感到兴奋
  • SAIA股票已做好换挡走高的准备
  • Meta平台股票崩盘是难得的买入机会吗?

Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.

接受MusclePharm日报的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯收到对MusclePharm和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发